Search Results 731-740 of 17358 for maca benefits

1. A Study of RoActemra/Actemra (Tocilizumab) in Comparison to Etanercept in Patients With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors - Mayo Clinic

   ... benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety ...

2. Travis J. McKenzie, M.D. - Mayo Clinic Faculty Profiles

   Mayo Clinic researcher Travis J. McKenzie, M.D., specializes in endocrine surgery and adrenal disease, giving hope to patients for new treatments and better ...

3. A Global Phase III Study Of Rilvegostomig Or Pembrolizumab Plus Chemotherapy For First-Line Treatment Of Metastatic Non-squamous NSCLC - Mayo Clinic

   ... benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety ...

4. OBS in Adolescent and Adults with EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study with an Open Label Extension - Mayo Clinic

   ... benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety ...

5. A Study of JNJ-68284528, a Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   ... benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety ...

6. A Study to Assess Point of Care Platelet Function - Mayo Clinic

   About this study. The purpose of this study is to compare Placor outputs between two groups (Group 1, healthy donors and Group 2, not acutely ill donors ...

7. Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab - Mayo Clinic

   ... benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety ...

8. Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III - Mayo Clinic

   ... benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety ...

9. Standard of Care +/- Midostaurin to Prevent Relapse Post Stem Cell Transplant in Patients With FLT3-ITD Mutated AML - Mayo Clinic

   ... benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety ...

10. Obinutuzumab With or Without PI3K-delta Inhibitor TGR-1202, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma - Mayo Clinic

    ... benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety ...